文献速递神经核医学肿瘤 PET/CT

人工智能驱动的Flortaucipir PET定量用于检测Tau病理

Artificial Intelligence-Powered Quantification of Flortaucipir PET for Detecting Tau Pathology.
PubMed 文献 · J Nucl Med · 2025-11-03

研究开发并评估了一种无需结构MRI的人工智能驱动Tau PET定量方法,利用深度学习模型将18F-AV1451 PET图像标准化至标准模板,并在阿尔茨海默病神经影像学倡议外部数据集验证。模型推导的Tau摄取估计与MR基准的组内相关系数超过0.97,且颞中叶Tau沉积与认知量表评分显著相关,内嗅皮层与颞下回Tau摄取升高可预测未来认知下降。

要点

  • AI驱动流程无需结构MRI即可定量Tau PET,区域摄取估计与MR基准的组内相关系数超过0.97。
  • 颞中叶Tau沉积与简易精神状态检查及蒙特利尔认知评估评分显著相关。
  • 内嗅皮层与颞下回Tau PET摄取升高可预测未来认知下降。

核心结论

  • 所提出的AI驱动流程通过降低扫描成本和简化摄取定量,提高了Tau PET的临床可及性,无需结构MRI即可实现高性能。
  • 该流程可产生与认知相关的结局指标,用于阿尔茨海默病的早期诊断和进展监测,以辅助针对阿尔茨海默病生物标志物的更个性化治疗策略。

研究设计与样本

  • 研究实现了一个深度神经网络模型,利用从淀粉样蛋白PET预训练模型迁移学习,将18F-AV1451(Tau)PET图像标准化至标准模板而无需MRI。
  • 该模型被整合进无MRI的Tau PET定量流程,并在外部数据集(阿尔茨海默病神经影像学倡议)上验证。
  • 研究分析了模型推导的Tau摄取估计与认知指标(包括阿尔茨海默病分期和情景记忆表现)之间的相关性(n=666)。
  • 研究进行了纵向分析,评估基线Tau沉积是否预测未来认知下降(n=168)。

主要发现

  • AI驱动流程表现稳健,区域摄取估计与基于MR的基准相比,组内相关系数超过0.97。
  • 颞中叶区域的Tau沉积与简易精神状态检查评分和蒙特利尔认知评估评分显著相关。
  • 内嗅皮层和颞下回的Tau PET摄取升高预测了未来认知下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We developed and evaluated an artificial intelligence (AI)-powered approach for easier quantification of tau PET uptake without requiring structural MR to aid earlier tracking of Alzheimer disease (AD). Methods: We implemented a deep neural network model that normalizes 18F-AV1451 (tau) PET images to a standard template without requiring MR, using transfer learning from a model pretrained on amyloid PET. This model was integrated into an MR-free pipeline for tau PET quantification and validated on external dataset (Alzheimer Disease Neuroimaging Initiative). We examined correlations between model-derived tau uptake estimates and cognitive measures, including AD stage and episodic memory performance (n = 666). Longitudinal analyses were conducted to assess whether baseline tau deposition predicted future cognitive decline (n = 168). Results: The AI-powered pipeline achieved robust performance with intraclass correlation coefficients exceeding 0.97 for regional uptake estimation compared with MR-based ground truth. We also showed that the tau deposition in metatemporal regions was significantly correlated with Mini-Mental State Examination and Montreal Cognitive Assessment scores. Elevated tau PET uptake in the entorhinal cortex and inferior temporal gyrus predicted future cognitive decline. Conclusion: The proposed AI-powered pipeline enhances the clinical accessibility of tau PET by reducing scan costs and streamlining the uptake quantification, achieving high performance without requiring structural MR. We further demonstrated that the pipeline yields cognitively relevant outcome measures for early diagnosis and monitoring of AD progression to aid more personalized treatment strategies targeting AD biomarkers.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yoo HB, Kang SK, Shin SA, et al. Artificial Intelligence-Powered Quantification of Flortaucipir PET for Detecting Tau Pathology. J Nucl Med. 2025. PMID: 40935607. doi:10.2967/jnumed.125.269636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。